Idera reports positive data By: MarketMinute.com Stock News December 03, 2014 at 17:31 PM EST Idera Pharmaceuticals Inc. (Nasdaq: IDRA) reported positive preclinical data for its cancer treatment IMO-2055. The stock price rose 49 cents to close at $4.07. Related Stocks: Idera Pharmaceuticals